Fig. 2From: Personalized pancreatic cancer therapy: from the perspective of mRNA vaccineStreamlined development of personalized mRNA vaccines for pancreatic cancer. Novel tumor antigens are identified as potent targets for the preparation of promising pancreatic cancer mRNA vaccines. Immune subtypes are identified as vital criteria for selecting applicable pancreatic cancer patients for mRNA vaccine treatment. Partial elements of this figure are adopted from Huang et al. [29] with appropriate modification. ORF open reading frame, DC dendritic cell, APCs antigen-presenting cells, OS overall survival, RFS relapse-free survivalBack to article page